Cited by 94Effects of Radiation ExposureRadiation Therapy and DosimetryRadiation Dose and Imaging

The DOI matches its Crossref record; the references it cites are not checked yet.

Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy

Open access
Schneider, Uwe, Walsh, Linda·2008·Radiation and Environmental Biophysics

Abstract

Most information on the dose-response of radiation-induced cancer is derived from data on the A-bomb survivors who were exposed to gamma-rays and neutrons. Since, for radiation protection purposes, the dose span of main interest is between 0 and 1 Gy, the analysis of the A-bomb survivors is usually focused on this range. However, estimates of cancer risk for doses above 1 Gy are becoming more important for radiotherapy patients and for long-term manned missions in space research. Therefore in this work, emphasis is placed on doses relevant for radiotherapy with respect to radiation-induced solid cancer. The analysis of the A-bomb survivor's data was extended by including two extra high-dose categories (4-6 Sv and 6-13 Sv) and by an attempted combination with cancer data on patients receiving radiotherapy for Hodgkin's disease. In addition, since there are some recent indications for a high neutron dose contribution, the data were fitted separately for three different values for the relative biological effectiveness (RBE) of the neutrons (10, 35 and 100) and a variable RBE as a function of dose. The data were fitted using a linear, a linear-exponential and a plateau-dose-response relationship. Best agreement was found for the plateau model with a dose-varying RBE. It can be concluded that for doses above 1 Gy there is a tendency for a nonlinear dose-response curve. In addition, there is evidence of a neutron RBE greater than 10 for the A-bomb survivor data. Many problems and uncertainties are involved in combing these two datasets. However, since very little is currently known about the shape of dose-response relationships for radiation-induced cancer in the radiotherapy dose range, this approach could be regarded as a first attempt to acquire more information on this area. The work presented here also provides the first direct evidence that the bending over of the solid cancer excess risk dose response curve for the A-bomb survivors, generally observed above 2 Gy, is due to cell killing effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00411-007-0151-y

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 32 · Cited by 94

Metadata

Authors
Schneider, U., & Walsh, L.
Affiliations
  • Triemli Hospital (CH)
  • Helmholtz Munich (DE)
Corresponding author
Schneider, Uwe
Venue
Radiation and Environmental Biophysics
Published
2007-12-21
Volume
47
Issue
2
Pages
253-263
ISSN
  • 0301-634X (ISSN-L)
  • 1432-2099
OpenAlex
W1984191665
Cited by
94
References
32
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 10 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 4
FWCI
2.75
Type
journal article
Language
en
Open access
Locations
  • Radiation and Environmental Biophysics (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • reroDoc Digital Library (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • U.S. Department of Energy
  • National Academy of Sciences
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiation Dose and Imaging
Keywords
radiation-induced cancer, cancer risk assessment, dose-response relationship, atomic bomb survivors, high-dose irradiation, space radiation protection
MeSH terms
Body Burden, Dose-Response Relationship, Radiation, Hodgkin Disease, Humans, Japan, Neoplasms, Radiation-Induced, Nuclear Warfare, Radiotherapy, Radiotherapy Dosage, Relative Biological Effectiveness, Risk Factors, Incidence, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review